Year archive

Eupraxia Pharmaceuticals Inc. — 2024 filings

All 49 regulatory filings released by Eupraxia Pharmaceuticals Inc. (EPRX) in 2024, sourced directly from the official regulator.

49 Filings

2024 Period

2024 filings (49)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2024-11-20	English
News release - English.pdf Investor Presentation	2024-11-14	English
News release - English.pdf Regulatory Filings	2024-11-13	English
Other securityholders documents - English.pdf Regulatory Filings	2024-11-01	English
News release - English.pdf Capital/Financing Update	2024-11-01	English
News release - English.pdf Regulatory Filings	2024-10-15	English
News release - English.pdf Regulatory Filings	2024-10-10	English
Material change report - English.pdf Board/Management Information	2024-10-03	English
News release - English.pdf Board/Management Information	2024-10-02	English
News release - English.pdf Investor Presentation	2024-09-19	English
News release - English.pdf Regulatory Filings	2024-09-11	English
News release - English.pdf Capital/Financing Update	2024-08-02	English
News release - English.pdf Investor Presentation	2024-07-03	English
Report of voting results.pdf Declaration of Voting Results & Voting Rights Announcements	2024-06-06	English
News release - English.pdf Declaration of Voting Results & Voting Rights Announcements	2024-06-06	English
News release - English.pdf Investor Presentation	2024-06-05	English
News release - English.pdf Capital/Financing Update	2024-05-23	English
News release - English.pdf Investor Presentation	2024-05-22	English
News release - English.pdf Investor Presentation	2024-05-14	English
News release - English.pdf Interim / Quarterly Report	2024-05-08	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-05-08	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-05-08	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-05-08	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-05-08	English
News release - English.pdf Regulatory Filings	2024-05-02	English
Material change report - English.pdf Regulatory Filings	2024-04-08	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2024-04-08	English
News release - English.pdf Investor Presentation	2024-04-08	English
News release - English.pdf Regulatory Filings	2024-04-05	English
News release - English.pdf Capital/Financing Update	2024-04-03	English
Material change report - English.pdf Regulatory Filings	2024-03-18	English
Material change report - English.pdf Capital/Financing Update	2024-03-18	English
News release - English.pdf Capital/Financing Update	2024-03-15	English
Notice to the Public.pdf Regulatory Filings	2024-02-06	English
News release - English.pdf Regulatory Filings	2024-02-05	English
Decision Document (Final).pdf Regulatory Filings	2024-02-05	English
Undertaking re novel derivatives or asset-backed securities.pdf Regulatory Filings	2024-02-05	English
Undertaking re breakdown of sales and payment of fees (BC).pdf Regulatory Filings	2024-02-05	English
Consent letter of issuer's legal counsel.pdf Regulatory Filings	2024-02-05	English
Non-issuer's submission to jurisdiction and appointment of agent.pdf Regulatory Filings	2024-02-05	English
Other undertakings.pdf Regulatory Filings	2024-02-05	English
Auditors' consent letter.pdf Regulatory Filings	2024-02-05	English
Final short form prospectus – English.pdf Capital/Financing Update	2024-02-05	English
Decision Document (Amendment to Preliminary).pdf Regulatory Filings	2024-01-19	English
Amendment to (or amended) preliminary short form prospectus – English.pdf Capital/Financing Update	2024-01-18	English
News release - English.pdf Capital/Financing Update	2024-01-09	English
Decision Document (Preliminary).pdf Regulatory Filings	2024-01-08	English
Qualification certificate.pdf Regulatory Filings	2024-01-06	English
Preliminary short form prospectus – English.pdf Capital/Financing Update	2024-01-06	English